• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳酸氢盐缓冲液对药物人工膜渗透的影响。

Effect of bicarbonate buffer on artificial membrane permeation of drugs.

作者信息

Ishida Shiori, Lee Samuel, Sinko Balint, Box Karl, Sugano Kiyohiko

机构信息

Molecular Pharmaceutics Lab., College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1, Noji-higashi, Kusatsu, Shiga 525-8577, Japan.

Pion Inc. (UK) Ltd. Forest Row Business Park, Station Road, East Sussex, RH18 5DW, United Kingdom.

出版信息

ADMET DMPK. 2025 Jan 18;13(1):2603. doi: 10.5599/admet.2603. eCollection 2025.

DOI:10.5599/admet.2603
PMID:40161892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11954139/
Abstract

BACKGROUND AND PURPOSE

The pH value of the small intestine is physiologically maintained by bicarbonate buffer (BCB). However, the effect of BCB on the membrane permeation of drugs has not been investigated. The purpose of this study was to investigate the effect of BCB on the passive membrane permeation of drugs.

EXPERIMENTAL APPROACH

The μFlux apparatus (pION Inc.) was used for permeability measurements. To avoid a pH change of BCB, a floating lid was newly developed for μFlux. The membrane filter was coated with a 10 % soybean lecithin-decane solution. The flux measurement was performed in an iso-pH condition (pH 6.5, BCB = 10 mM, buffer capacity ()= 4.4 mM pH). Phosphate buffer (PPB) with the same pH and was used for comparison (PPB = 8 mM).

KEY RESULTS

The floating lid suppressed the pH increase to less than 0.1 for 120 min. The effective permeability ( ) values of lipophilic weakly acidic and basic drugs were lower in BCB than in PPB (ketoprofen, naproxen, and propranolol). On the other hand, the values in BCB and PPB were similar for unionizable drugs (caffeine and antipyrine) and hydrophilic weakly basic drugs (metoprolol and procainamide).

CONCLUSION

Passive membrane permeation of lipophilic weakly acidic and basic drugs was slower in BCB than in PPB. This was suggested to be attributed to the slow neutralization rate of BCB, which affects the pH value adjacent to the membrane surface.

摘要

背景与目的

小肠的pH值通过碳酸氢盐缓冲液(BCB)在生理状态下维持。然而,BCB对药物膜渗透的影响尚未得到研究。本研究的目的是探究BCB对药物被动膜渗透的影响。

实验方法

使用μFlux仪器(pION公司)进行渗透性测量。为避免BCB的pH值变化,新开发了一种用于μFlux的浮动盖。膜过滤器用10%大豆卵磷脂-癸烷溶液包被。通量测量在等pH条件下进行(pH 6.5,BCB = 10 mM,缓冲容量()= 4.4 mM pH)。使用具有相同pH和的磷酸盐缓冲液(PPB)进行比较(PPB = 8 mM)。

关键结果

浮动盖在120分钟内将pH值升高抑制至小于0.1。亲脂性弱酸和弱碱性药物在BCB中的有效渗透率()值低于在PPB中的值(酮洛芬、萘普生和普萘洛尔)。另一方面,对于非离子化药物(咖啡因和安替比林)和亲水性弱碱性药物(美托洛尔和普鲁卡因胺),BCB和PPB中的值相似。

结论

亲脂性弱酸和弱碱性药物在BCB中的被动膜渗透比在PPB中慢。这被认为归因于BCB的缓慢中和速率,其影响膜表面附近的pH值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/f65a76bd445d/ADMET-13-2603-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/05c33747ba64/ADMET-13-2603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/fe58f48e2832/ADMET-13-2603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/4134fae5db08/ADMET-13-2603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/e63d63f57f6c/ADMET-13-2603-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/dc352fe4a341/ADMET-13-2603-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/f65a76bd445d/ADMET-13-2603-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/05c33747ba64/ADMET-13-2603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/fe58f48e2832/ADMET-13-2603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/4134fae5db08/ADMET-13-2603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/e63d63f57f6c/ADMET-13-2603-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/dc352fe4a341/ADMET-13-2603-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/11954139/f65a76bd445d/ADMET-13-2603-g006.jpg

相似文献

1
Effect of bicarbonate buffer on artificial membrane permeation of drugs.碳酸氢盐缓冲液对药物人工膜渗透的影响。
ADMET DMPK. 2025 Jan 18;13(1):2603. doi: 10.5599/admet.2603. eCollection 2025.
2
Effect of pH and Buffer Capacity of Physiological Bicarbonate Buffer on Precipitation of Drugs.生理碳酸氢盐缓冲液的pH值和缓冲容量对药物沉淀的影响。
Mol Pharm. 2025 Mar 3;22(3):1318-1328. doi: 10.1021/acs.molpharmaceut.4c00996. Epub 2025 Feb 2.
3
Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer.生物相关碳酸氢盐缓冲液中的药物晶体沉淀:与磷酸盐缓冲液的良好对照比较研究。
Mol Pharm. 2024 Jun 3;21(6):2854-2864. doi: 10.1021/acs.molpharmaceut.4c00028. Epub 2024 May 8.
4
Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.各种药物速释制剂在生物相关碳酸氢盐缓冲液中的溶出曲线:与药典磷酸盐缓冲液的比较。
Pharm Res. 2024 May;41(5):959-966. doi: 10.1007/s11095-024-03701-6. Epub 2024 Apr 23.
5
Dissolution profiles of high-dose salt-form drugs in bicarbonate buffer and phosphate buffer.高剂量盐型药物在碳酸氢盐缓冲液和磷酸盐缓冲液中的溶出曲线。
J Pharm Sci. 2025 Jan;114(1):477-485. doi: 10.1016/j.xphs.2024.10.025. Epub 2024 Oct 31.
6
Dissolution Profiles of Poorly Soluble Drug Salts in Bicarbonate Buffer.难溶性药物盐在碳酸氢盐缓冲液中的溶解曲线。
Pharm Res. 2023 Apr;40(4):989-998. doi: 10.1007/s11095-023-03508-x. Epub 2023 Apr 6.
7
Comparison of Phosphate and Bicarbonate Buffer Solutions as Dissolution Test Media for Predicting Bioequivalence of Febuxostat Formulation.比较磷酸盐和碳酸氢盐缓冲溶液作为溶解试验介质预测非布司他制剂生物等效性。
Chem Pharm Bull (Tokyo). 2024;72(11):989-995. doi: 10.1248/cpb.c24-00526.
8
Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.硝苯地平-可离子化聚合物无定形固体分散体的溶出动力学:碳酸氢盐和磷酸盐缓冲液的比较。
Pharm Res. 2021 Dec;38(12):2119-2127. doi: 10.1007/s11095-021-03153-2. Epub 2021 Dec 20.
9
Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test.对表现不佳的肠溶包衣产品的机制理解:在溶出试验中增加临床相关性的机会。
J Control Release. 2020 Sep 10;325:323-334. doi: 10.1016/j.jconrel.2020.06.031. Epub 2020 Jul 7.
10
Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.IAM-HPLC 指数中酸性药物与膜磷脂之间的亲脂性和极性相互作用力:它们在膜分配中的作用及与 BBB 渗透数据的关系。
J Pharm Biomed Anal. 2013 Mar 5;75:165-72. doi: 10.1016/j.jpba.2012.11.034. Epub 2012 Dec 1.

引用本文的文献

1
Dissolution Profile of Tosufloxacin Tosylate in Biorelevant Bicarbonate Buffer Containing Sodium Chloride: Precipitation of Hemi-hydrochloride Salt at the Particle Surface.托氟沙星甲苯磺酸盐在含氯化钠的生物相关碳酸氢盐缓冲液中的溶出曲线:颗粒表面半盐酸盐的沉淀
Pharm Res. 2025 Aug;42(8):1363-1372. doi: 10.1007/s11095-025-03905-4. Epub 2025 Aug 11.
2
Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio.生物相关碳酸氢盐缓冲液中盐型药物溶出曲线与口服药物吸收之间的相关性:剂量/液体体积比的重要性。
Pharm Res. 2025 Apr;42(4):623-637. doi: 10.1007/s11095-025-03854-y. Epub 2025 Apr 4.

本文引用的文献

1
Comparison of Phosphate and Bicarbonate Buffer Solutions as Dissolution Test Media for Predicting Bioequivalence of Febuxostat Formulation.比较磷酸盐和碳酸氢盐缓冲溶液作为溶解试验介质预测非布司他制剂生物等效性。
Chem Pharm Bull (Tokyo). 2024;72(11):989-995. doi: 10.1248/cpb.c24-00526.
2
Dissolution profiles of high-dose salt-form drugs in bicarbonate buffer and phosphate buffer.高剂量盐型药物在碳酸氢盐缓冲液和磷酸盐缓冲液中的溶出曲线。
J Pharm Sci. 2025 Jan;114(1):477-485. doi: 10.1016/j.xphs.2024.10.025. Epub 2024 Oct 31.
3
Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer.
生物相关碳酸氢盐缓冲液中的药物晶体沉淀:与磷酸盐缓冲液的良好对照比较研究。
Mol Pharm. 2024 Jun 3;21(6):2854-2864. doi: 10.1021/acs.molpharmaceut.4c00028. Epub 2024 May 8.
4
Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.各种药物速释制剂在生物相关碳酸氢盐缓冲液中的溶出曲线:与药典磷酸盐缓冲液的比较。
Pharm Res. 2024 May;41(5):959-966. doi: 10.1007/s11095-024-03701-6. Epub 2024 Apr 23.
5
Dissolution Profiles of Oral Disintegrating Tablet with Taste Masking Granule Polymer Coating in Biorelevant Bicarbonate Buffer.口腔崩解片的溶出度研究-采用味觉掩蔽颗粒聚合物包衣的口腔崩解片在生物相关碳酸氢盐缓冲液中的溶出度。
Chem Pharm Bull (Tokyo). 2024;72(3):298-302. doi: 10.1248/cpb.c23-00783.
6
Bicarbonate buffer dissolution test with gentle mechanistic stress for bioequivalence prediction of enteric-coated pellet formulations.用于肠溶包衣微丸制剂生物等效性预测的伴有温和机械应力的碳酸氢盐缓冲液溶出度试验。
Eur J Pharm Sci. 2024 Jan 1;192:106622. doi: 10.1016/j.ejps.2023.106622. Epub 2023 Oct 24.
7
Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing.磷酸盐缓冲液会干扰盐酸哌唑嗪在药典溶出度测试中的溶解。
Drug Metab Pharmacokinet. 2023 Aug;51:100519. doi: 10.1016/j.dmpk.2023.100519. Epub 2023 Jun 10.
8
Dissolution Profiles of Poorly Soluble Drug Salts in Bicarbonate Buffer.难溶性药物盐在碳酸氢盐缓冲液中的溶解曲线。
Pharm Res. 2023 Apr;40(4):989-998. doi: 10.1007/s11095-023-03508-x. Epub 2023 Apr 6.
9
Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets.碳酸氢盐缓冲液流通池溶出度试验的建立及其在结肠靶向片剂体内性能预测中的应用。
Eur J Pharm Sci. 2023 Jan 1;180:106326. doi: 10.1016/j.ejps.2022.106326. Epub 2022 Nov 5.
10
Permeation characteristics of tetracyclines in parallel artificial membrane permeation assay.四环素在平行人工膜渗透试验中的渗透特性
ADMET DMPK. 2019 May 8;7(3):151-160. doi: 10.5599/admet.657. eCollection 2019.